1-6 of 6
Kaihong Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multi-omics profiling of the gut Microbiota–Metabolism–Immunity axis reveals predictive biomarkers of treatment response and survival in diffuse large B-cell lymphoma

Free
Lixia Sheng, Changyu Jin, Huijie Hu, Yanli Lai, Huiying Qiu, Shasha You, Jiaping Wang, Shuyan Wang, Yan Xiong, Li Hu, Kaihong Xu, Ping Zhang, Yongcheng Sun, Lieguang Chen, Shanhao Tang, Xiao Wu, Yi Zhang, Qitian Mu, Tongyu Li, Xinjun Wang, Guifang Ouyang
Journal: Blood
Blood (2025) 146 (Supplement 1): 3533.
https://doi.org/10.1182/blood-2025-3533
Published: 2025
Journal Articles

MBS314, a GPRC5DxBCMAxCD3 trispecific antibody, in relapsed/refractory multiple myeloma (RRMM): Updated results from a Phase 1 dose escalation study

Free
Gang An, Wenming Chen, Wen Gao, Ting Yang, Lijie Xing, Kaihong Xu, Yan Zhang, Tong Xu, Min Wei, Feng Li, Guojin Wu, Jinying Ning, Lugui Qiu
Journal: Blood
Blood (2025) 146 (Supplement 1): 2274.
https://doi.org/10.1182/blood-2025-2274
Published: 2025
Journal Articles

Efficacy and safety observation of luspatercept for refractory anemia associated with hematologic malignanciesluspatercept治疗血液系统恶性肿瘤相关难治性贫血的疗效和安全性观察luspatercept 改善与血液系统恶性肿瘤相关的难治性贫血的疗效和安全性：一项观察

Free
Ping Zhang, Shuling Yu, Shengfa Gao, Huiling Zhu, Shanhao Tang, Yongcheng Sun, Binbin Lai, Xiao Wu, Lieguang Chen, Kaihong Xu, Lixia Sheng, Guifang Ouyang
Journal: Blood
Blood (2025) 146 (Supplement 1): 2888.
https://doi.org/10.1182/blood-2025-2888
Published: 2025
Journal Articles

Timed PD-1 blockade synergizes with IL-7/CCL19 armoring to reverse CAR-T exhaustion in PD-L1-high large B-cell lymphoma

Free
Lixia Sheng, Wen Lei, Duo Wu, Yi Zhang, Yanli Lai, Shuyan Wang, Duobing Zou, Ping Zhang, Kaihong Xu, Shanhao Tang, Huijie Hu, Tongyu Li, Qitian Mu, Xiaofei Ye, Hui Liu, Wenbin Qian, Guifang Ouyang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1929.
https://doi.org/10.1182/blood-2025-1929
Published: 2025
Journal Articles

Mid-treatment CSF ctdna and MYD88 clearance outperform PET-CT in predicting response and survival to orelabrutinib-based induction in newly diagnosed PCNSL: A prospective biomarker study

Free
Lixia Sheng, Yanli Lai, Sheng Nie, Yuning Pan, Di Wang, Shanhao Tang, Kaihong Xu, Yongcheng Sun, Ping Zhang, Binbin Lai, Lieguang Chen, Guifang Ouyang
Journal: Blood
Blood (2025) 146 (Supplement 1): 59.
https://doi.org/10.1182/blood-2025-59
Published: 2025
Journal Articles

Preliminary Data on the Efficacy and Safety of Orelabrutinib Combined with Rituximab and Methotrexate (ORM Regimen) As First-Line Treatment for Primary Central Nervous System Lymphoma, and the Exploration of Cerebrospinal Fluid Ctdna Dynamic Monitoring

Free
Lixia Sheng, Guifang Ouyang, Yanli Lai, Sheng Nie, Di Wang, Shanhao Tang, Yuning Pan, Kaihong Xu, Yongcheng Sun, Ping Zhang, Binbin Lai, Lieguang Chen
Journal: Blood
Blood (2024) 144 (Supplement 1): 4500.
https://doi.org/10.1182/blood-2024-198355
Published: 2024